Generic Hycodan Availability
Last updated on May 7, 2025.
Hycodan is a brand name of homatropine/hydrocodone, approved by the FDA in the following formulation(s):
HYCODAN (homatropine methylbromide; hydrocodone bitartrate - syrup;oral)
HYCODAN (homatropine methylbromide; hydrocodone bitartrate - tablet;oral)
Is there a generic version of Hycodan available?
Yes. The following products are equivalent to Hycodan:
HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE (homatropine methylbromide; hydrocodone bitartrate tablet;oral)
-
Manufacturer: AVANTHI INC
Approval date: August 7, 2017
Strength(s): 1.5MG;5MG [AA]
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE (homatropine methylbromide; hydrocodone bitartrate syrup;oral)
-
Manufacturer: ABHAI LLC
Approval date: February 21, 2017
Strength(s): 1.5MG/5ML;5MG/5ML [AA] -
Manufacturer: ACTAVIS MID ATLANTIC
Approval date: July 5, 1983
Strength(s): 1.5MG/5ML;5MG/5ML [AA] -
Manufacturer: NOVEL LABS INC
Approval date: February 13, 2017
Strength(s): 1.5MG/5ML;5MG/5ML [AA] -
Manufacturer: PADAGIS US
Approval date: February 15, 2017
Strength(s): 1.5MG/5ML;5MG/5ML [AA] -
Manufacturer: XTTRIUM LABS INC
Approval date: March 3, 1983
Strength(s): 1.5MG/5ML;5MG/5ML [AA]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Hycodan. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: Generic Drug FAQ.
More about Hycodan (homatropine / hydrocodone)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (37)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Related/similar drugs
Benadryl
Benadryl is an antihistamine and is used to treat sneezing, runny nose, itching and other ...
Mucinex
Mucinex (guaifenesin) is used to relieve the symptoms of cough and loosen mucus in the chest ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Norco
Norco (acetaminophen and hydrocodone) is used to relieve moderate to severe pain. Includes Norco ...
Dilaudid
Dilaudid (hydromorphone) is a narcotic pain reliever used to treat moderate to severe pain ...
Vicodin
Vicodin (acetaminophen and hydrocodone) is used to relieve moderate to severe pain. Includes ...
Codeine
Codeine is a opioid pain medicine used to treat mild to moderate pain. Includes codeine side ...
Hydromorphone
Hydromorphone systemic is used for anesthetic adjunct, chronic pain, cough, pain
Dextromethorphan
Dextromethorphan is a cough suppressant used to treat coughing. Learn about side effects ...
Guaifenesin
Guaifenesin is an expectorant. It helps loosen congestion in your chest and throat. Includes ...
Glossary
| Term | Definition |
|---|---|
| Drug Patent | A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation. |
| Drug Exclusivity | Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant. |
| RLD | A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. |
| AA | Products in conventional dosage forms not presenting bioequivalence problems. Products coded as AA contain active ingredients and dosage forms that are not regarded as presenting either actual or potential bioequivalence problems or drug quality or standards issues. However, all oral dosage forms must, nonetheless, meet an appropriate in vitro bioequivalence standard that is acceptable to the Agency in order to be approved. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
